Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Verchere, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Verchere, C. B.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:534-539, 2001
© 2001 by the American Diabetes Association, Inc.

The Prohormone Convertase Enzyme 2 (PC2) Is Essential for Processing Pro-Islet Amyloid Polypeptide at the NH2-Terminal Cleavage Site

Jing Wang1, Jun Xu1, Jennifer Finnerty1, Machi Furuta2, Donald F. Steiner2, and C. Bruce Verchere1

1 Department of Pathology and Laboratory Medicine and the British Columbia Research Institute for Children’s and Women’s Health, University of British Columbia, Vancouver, British Columbia, Canada
2 Department of Biochemistry and Molecular Biology, Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois.

Impaired processing of pro-islet amyloid polypeptide (proIAPP), the precursor of the ß-cell peptide islet amyloid polypeptide (IAPP) (amylin), has been implicated in islet amyloid formation in type 2 diabetes. The prohormone convertase enzymes PC3 (also known as PC1) and PC2 are localized to ß-cell secretory granules with proIAPP and proinsulin and are responsible for proinsulin processing. To determine whether PC2 might be essential for proIAPP processing, we performed Western blot analysis of freshly isolated islets from normal mice and mice lacking active PC2. As expected, the primary species of IAPP immunoreactivity in islets from wild-type mice was fully processed (4-kDa) IAPP, with only small amounts of the 8-kDa precursor (unprocessed proIAPP) present. Islets from heterozygous PC2 null mice were identical to wild-type animals, suggesting that half the normal complement of PC2 is sufficient for normal proIAPP processing. By contrast, in islets from homozygous PC2 null mice, the predominant IAPP-immunoreactive form was of intermediate size (~6 kDa), with no detectable mature IAPP and slightly elevated amounts of the 8-kDa precursor form present. Thus, in the absence of PC2, proIAPP processing appears to be blocked at the level of a proIAPP conversion intermediate. Immunofluorescence of pancreas sections and immunoblotting using antisera raised to the NH2- and COOH-terminal flanking regions of mouse proIAPP demonstrated that the 6-kDa intermediate form was an NH2-terminally extended proIAPP conversion intermediate (processed only at the COOH-terminus). These data indicate that PC2 is essential for processing of proIAPP at the NH2-terminal cleavage site in vivo and that PC3 is likely only capable of processing proIAPP at the COOH-terminal cleavage site.

Abbreviations: B-C, B-chain/C-peptide; BSA, bovine serum albumin; C-A, C-peptide/A-chain; CPE, carboxypeptidase E; HBSS, Hanks’ balanced salt solution; IAPP, islet amyloid polypeptide; PBS, phosphate-buffered saline


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
V. P. Espinosa, M. Ferrini, X. Shen, K. Lutfy, E. A. Nillni, and T. C. Friedman
Cellular colocalization and coregulation between hypothalamic pro-TRH and prohormone convertases in hypothyroidism
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E175 - E186.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. Marzban, C. J. Rhodes, D. F. Steiner, L. Haataja, P. A. Halban, and C. B. Verchere
Impaired NH2-Terminal Processing of Human Proislet Amyloid Polypeptide by the Prohormone Convertase PC2 Leads to Amyloid Formation and Cell Death.
Diabetes, August 1, 2006; 55(8): 2192 - 2201.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Ugleholdt, M.-L. H. Poulsen, P. J. Holst, J.-C. Irminger, C. Orskov, J. Pedersen, M. M. Rosenkilde, X. Zhu, D. F. Steiner, and J. J. Holst
Prohormone Convertase 1/3 Is Essential for Processing of the Glucose-dependent Insulinotropic Polypeptide Precursor
J. Biol. Chem., April 21, 2006; 281(16): 11050 - 11057.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. Marzban, G. Trigo-Gonzalez, and C. B. Verchere
Processing of Pro-Islet Amyloid Polypeptide in the Constitutive and Regulated Secretory Pathways of {beta} Cells
Mol. Endocrinol., August 1, 2005; 19(8): 2154 - 2163.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. F. Paulsson and G. T. Westermark
Aberrant Processing of Human Proislet Amyloid Polypeptide Results in Increased Amyloid Formation
Diabetes, July 1, 2005; 54(7): 2117 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Marzban, G. Soukhatcheva, and C. B. Verchere
Role of Carboxypeptidase E in Processing of Pro-Islet Amyloid Polypeptide in {beta}-Cells
Endocrinology, April 1, 2005; 146(4): 1808 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
X. Shen, Q.-L. Li, G. A. Brent, and T. C. Friedman
Regulation of regional expression in rat brain PC2 by thyroid hormone/characterization of novel negative thyroid hormone response elements in the PC2 promoter
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E236 - E245.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. H. J. Lopes, C. Colin, T. L. Degaki, A. C. V. de Sousa, M. N. N. Vieira, A. Sebollela, A. M. B. Martinez, C. Bloch Jr., S. T. Ferreira, and M. C. Sogayar
Amyloidogenicity and Cytotoxicity of Recombinant Mature Human Islet Amyloid Polypeptide (rhIAPP)
J. Biol. Chem., October 8, 2004; 279(41): 42803 - 42810.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. L. Hull, G. T. Westermark, P. Westermark, and S. E. Kahn
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3629 - 3643.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Andrikopoulos, R. L. Hull, C. B. Verchere, F. Wang, S. M. Wilbur, T. N. Wight, L. Marzban, and S. E. Kahn
Extended life span is associated with insulin resistance in a transgenic mouse model of insulinoma secreting human islet amyloid polypeptide
Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E418 - E424.
[Abstract] [Full Text]

Home page
 DiabetesHome page
L. Marzban, G. Trigo-Gonzalez, X. Zhu, C. J. Rhodes, P. A. Halban, D. F. Steiner, and C. B. Verchere
Role of {beta}-Cell Prohormone Convertase (PC)1/3 in Processing of Pro-Islet Amyloid Polypeptide
Diabetes, January 1, 2004; 53(1): 141 - 148.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
N. A. TAYLOR, W. J. M. VAN DE VEN, and J. W. M. CREEMERS
Curbing activation: proprotein convertases in homeostasis and pathology
FASEB J, July 1, 2003; 17(10): 1215 - 1227.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. W. Gelling, X. Q. Du, D. S. Dichmann, J. Romer, H. Huang, L. Cui, S. Obici, B. Tang, J. J. Holst, C. Fledelius, et al.
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice
PNAS, February 4, 2003; 100(3): 1438 - 1443.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. L. Hull, S. Andrikopoulos, C. B. Verchere, J. Vidal, F. Wang, M. Cnop, R. L. Prigeon, and S. E. Kahn
Increased Dietary Fat Promotes Islet Amyloid Formation and {beta}-Cell Secretory Dysfunction in a Transgenic Mouse Model of Islet Amyloid
Diabetes, February 1, 2003; 52(2): 372 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. Zhu, L. Orci, R. Carroll, C. Norrbom, M. Ravazzola, and D. F. Steiner
Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3
PNAS, August 6, 2002; 99(16): 10299 - 10304.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Park and C. B. Verchere
Identification of a Heparin Binding Domain in the N-terminal Cleavage Site of Pro-islet Amyloid Polypeptide. IMPLICATIONS FOR ISLET AMYLOID FORMATION
J. Biol. Chem., May 11, 2001; 276(20): 16611 - 16616.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Furuta, A. Zhou, G. Webb, R. Carroll, M. Ravazzola, L. Orci, and D. F. Steiner
Severe Defect in Proglucagon Processing in Islet A-cells of Prohormone Convertase 2 Null Mice
J. Biol. Chem., July 13, 2001; 276(29): 27197 - 27202.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.